Skip to main content
Erschienen in: Diabetologia 2/2013

01.02.2013 | Short Communication

Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study

verfasst von: A. Hulmán, K. Færch, D. Vistisen, J. Karsai, T. A. Nyári, A. G. Tabák, E. J. Brunner, M. Kivimäki, D. R. Witte

Erschienen in: Diabetologia | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We aimed to study diurnal variation in glucose regulation by examining the effects of time of day and fasting duration on fasting plasma glucose (FPG), 2 h post-load plasma glucose (2hPG) and HbA1c levels.

Methods

We analysed data from 5,978 non-diabetic white men and women from the prospective Whitehall II Study. All studied participants fasted for at least 8 h before a clinical examination, which included an OGTT and anthropometric measurements. We fitted mixed-effects models for FPG, 2hPG and HbA1c as outcome variables, and time of day and/or fasting duration as explanatory variables. Models were adjusted for age, BMI and study phase.

Results

Time of day and fasting duration were associated inversely with FPG and positively with 2hPG. The mean difference between measures at 08:00 and 15:00 hours in men/women was −0.46 (95% CI −0.50, −0.42) mmol/l/−0.39 (95% CI −0.46, −0.31) mmol/l and 1.39 (95% CI 1.25, 1.52) mmol/l/1.19 (95% CI 0.96, 1.42) mmol/l for FPG and 2hPG, respectively. HbA1c levels were independent of either time. Time of day and fasting duration were independently associated with 2hPG. In contrast, the effect of fasting duration on FPG was markedly attenuated with adjustment for time of day. Ageing, but not obesity, was associated with increased diurnal variation in glucose tolerance.

Conclusions/interpretation

Both time of day and fasting duration should be considered in clinical practice and epidemiological studies, since they have clinically relevant effects on FPG and 2hPG levels. As biochemically expected, HbA1c levels are independent of time of blood sampling and fasting duration.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jarrett RJ, Keen H (1969) Diurnal variation of oral glucose tolerance: a possible pointer to the evolution of diabetes mellitus. BMJ 2:341–344PubMedCrossRef Jarrett RJ, Keen H (1969) Diurnal variation of oral glucose tolerance: a possible pointer to the evolution of diabetes mellitus. BMJ 2:341–344PubMedCrossRef
2.
Zurück zum Zitat Zimmet PZ, Wall JR, Rome R, Stimmler L, Jarrett RJ (1974) Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and non-esterified fatty acids. BMJ 1:485–488PubMedCrossRef Zimmet PZ, Wall JR, Rome R, Stimmler L, Jarrett RJ (1974) Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and non-esterified fatty acids. BMJ 1:485–488PubMedCrossRef
3.
Zurück zum Zitat Mayer KH, Stamler J, Dyer A et al (1976) Epidemiologic findings on the relationship of time of day and time since last meal to glucose tolerance. Diabetes 25:936–943PubMedCrossRef Mayer KH, Stamler J, Dyer A et al (1976) Epidemiologic findings on the relationship of time of day and time since last meal to glucose tolerance. Diabetes 25:936–943PubMedCrossRef
4.
Zurück zum Zitat Troisi RJ, Cowie CC, Harris MI (2000) Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 284:3157–3159PubMedCrossRef Troisi RJ, Cowie CC, Harris MI (2000) Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 284:3157–3159PubMedCrossRef
5.
Zurück zum Zitat Emberson JR, Whincup PH, Walker M, Thomas M, Alberti KGMM (2002) Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann Clin Biochem 39:493–501PubMedCrossRef Emberson JR, Whincup PH, Walker M, Thomas M, Alberti KGMM (2002) Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann Clin Biochem 39:493–501PubMedCrossRef
6.
Zurück zum Zitat Moebus S, Göres L, Lösch C, Jöckel K-H (2011) Impact of time since last caloric intake on blood glucose levels. Eur J Epidemiol 26:719–728PubMedCrossRef Moebus S, Göres L, Lösch C, Jöckel K-H (2011) Impact of time since last caloric intake on blood glucose levels. Eur J Epidemiol 26:719–728PubMedCrossRef
7.
Zurück zum Zitat Goldberg RJ, Ye C, Sermer M et al (2012) Circadian variation in the response to the glucose challenge test in pregnancy: implications for screening for gestational diabetes mellitus. Diabetes Care 35:1578–1584PubMedCrossRef Goldberg RJ, Ye C, Sermer M et al (2012) Circadian variation in the response to the glucose challenge test in pregnancy: implications for screening for gestational diabetes mellitus. Diabetes Care 35:1578–1584PubMedCrossRef
8.
Zurück zum Zitat Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221PubMedCrossRef Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221PubMedCrossRef
9.
Zurück zum Zitat Faerch K, Borch-Johnsen K, Vaag A, Jørgensen T, Witte DR (2010) Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53:858–865PubMedCrossRef Faerch K, Borch-Johnsen K, Vaag A, Jørgensen T, Witte DR (2010) Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53:858–865PubMedCrossRef
10.
Zurück zum Zitat Van Cauter E, Polonsky KS, Scheen AJ (1997) Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 18:716–738PubMedCrossRef Van Cauter E, Polonsky KS, Scheen AJ (1997) Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 18:716–738PubMedCrossRef
Metadaten
Titel
Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study
verfasst von
A. Hulmán
K. Færch
D. Vistisen
J. Karsai
T. A. Nyári
A. G. Tabák
E. J. Brunner
M. Kivimäki
D. R. Witte
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 2/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2770-3

Weitere Artikel der Ausgabe 2/2013

Diabetologia 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.